Lysosomal Storage Disease
 |
This article is still under construction. |
Description
Lysosomal storage diseases occur due to inherited deficiencies of various lysosomal enzymes and this may be due to abnormalities in their synthesis, processing or cellular trafficking. The normal function of lysosomes is to degrade molecules within the cell and, when these chemical reactions are truncated by the absence of a key enzyme, the substrates of the reaction accumulate within the organelle. Since there is some redundancy in the pathways by which proteins are degraded, deficiencies in proteases do not usually result in clinical disease. Deficiencies in the nuclease enzymes are also not usually compatible with survival.
There are a large number of different lysosomal storage diseases in dogs and cats categorised according to the product which accumulates within cells. All of the storage disease are rare.
Classification
| Class | Defective Enzyme | Name of Disease |
| Sphingolipidosis | beta D gangliosidase beta D hexosaminidase |
GM1 Gangliosidosis GM2 Gangliosidosis |
| Oligosaccharidosis | ||
| Mucopolysaccharidosis | ||
| Glycoproteinosis | ||
| Proteosis |
Pathophysiology
The clinical syndrome produced in each of the lysosomal storage disease results from the aberrant storage of metabolites within cells. The storage diseases usually affect multiple organs but some, such as those that are caused by a defect in the myelin degradation pathway, may only cause neurological signs.
The mucopolysaccharidoses involve a failure to degrade glycosaminoglycans (major components of cartilage) and they often involve skeletal deformity.
Diagnosis
Clinical Signs
Many of the lysosomal storage diseases are associated with neurological signs.
Laboratory Tests
Lysosonal storage disease often result in changes in leucocytic morphology which can be detected on a blood smear.
| Disease | Finding on blood smear |
Diagnostic Imaging
Other Tests
Since genetic techniques have become more widely available and easily performed, it is often possible to characterise the genetic defect directly by determining the sequence encoding enzymes thought to be deficient. However, it should be remembered that several lysosomal storage diseases result from alterations in post-translational processes such as cellular trafficking.